Suppr超能文献

白细胞介素-4对人γδ T细胞的新作用:通过产生白细胞介素-10促进调节性Vδ1 T细胞并抑制Vδ2 T细胞的功能。

A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cells.

作者信息

Mao Yujia, Yin Shanshan, Zhang Jianmin, Hu Yu, Huang Bo, Cui Lianxian, Kang Ning, He Wei

机构信息

Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China.

State Key Laboratory of Medical Molecular Biology, Beijing, China.

出版信息

Cell Mol Immunol. 2016 Mar;13(2):217-28. doi: 10.1038/cmi.2015.07. Epub 2015 Mar 16.

Abstract

Interleukin 4 (IL-4) has a variety of immune functions, including helper T-cell (Th-cell) differentiation and innate immune-response processes. However, the impact of IL-4 on gamma delta (γδ) T cells remains unclear. In this study, we investigate the effects of IL-4 on the activation and proliferation of γδ T cells and the balance between variable delta 1 (Vδ1) and Vδ2 T cells in humans. The results show that IL-4 inhibits the activation of γδ T cells in the presence of γδ T-cell receptor (TCR) stimulation in a STAT6-dependent manner. IL-4 promoted the growth of activated γδ T cells and increased the levels of Vδ1 T cells, which in turn inhibited Vδ2 T-cell growth via significant IL-10 secretion. Vδ1 T cells secreted significantly less interferon gamma (IFNγ) and more IL-10 relative to Vδ2. Furthermore, Vδ1 T cells showed relatively low levels of Natural Killer Group 2D (NKG2D) expression in the presence of IL-4, suggesting that Vδ1 T cells weaken the γδ T cell-mediated anti-tumor immune response. For the first time, our findings demonstrate a negative regulatory role of IL-4 in γδ T cell-mediated anti-tumor immunity.

摘要

白细胞介素4(IL-4)具有多种免疫功能,包括辅助性T细胞(Th细胞)分化和先天性免疫反应过程。然而,IL-4对γδ T细胞的影响仍不清楚。在本研究中,我们调查了IL-4对人类γδ T细胞活化和增殖以及可变δ1(Vδ1)和Vδ2 T细胞之间平衡的影响。结果表明,在存在γδ T细胞受体(TCR)刺激的情况下,IL-4以STAT6依赖的方式抑制γδ T细胞的活化。IL-4促进活化的γδ T细胞生长,并增加Vδ1 T细胞水平,进而通过大量分泌IL-10抑制Vδ2 T细胞生长。相对于Vδ2,Vδ1 T细胞分泌的干扰素γ(IFNγ)明显较少,而IL-10较多。此外,在存在IL-4的情况下,Vδ1 T细胞的自然杀伤细胞2D(NKG2D)表达水平相对较低,这表明Vδ1 T细胞削弱了γδ T细胞介导的抗肿瘤免疫反应。我们的研究结果首次证明了IL-4在γδ T细胞介导的抗肿瘤免疫中的负调节作用。

相似文献

3
Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Scand J Immunol. 2009 Sep;70(3):245-55. doi: 10.1111/j.1365-3083.2009.02290.x.
4
Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
World J Gastroenterol. 2016 Apr 7;22(13):3573-80. doi: 10.3748/wjg.v22.i13.3573.
5
Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection.
Transpl Immunol. 2013 Dec;29(1-4):118-22. doi: 10.1016/j.trim.2013.09.001. Epub 2013 Sep 10.
6
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
Cytotherapy. 2012 Oct;14(9):1110-8. doi: 10.3109/14653249.2012.700766. Epub 2012 Jul 17.
7
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
J Exp Med. 1996 Apr 1;183(4):1681-96. doi: 10.1084/jem.183.4.1681.
8
Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
Mol Immunol. 2006 May;43(12):2002-11. doi: 10.1016/j.molimm.2005.11.011. Epub 2006 Jan 19.
9
Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
J Immunol. 2024 Jan 15;212(2):284-294. doi: 10.4049/jimmunol.2300588.
10
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
Clin Cancer Res. 2014 Nov 15;20(22):5708-19. doi: 10.1158/1078-0432.CCR-13-3451. Epub 2014 May 15.

引用本文的文献

1
CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors.
Vaccines (Basel). 2025 Jun 19;13(6):654. doi: 10.3390/vaccines13060654.
3
Gamma delta T cells and their immunotherapeutic potential in cancer.
Biomark Res. 2025 Mar 28;13(1):51. doi: 10.1186/s40364-025-00762-6.
4
Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases.
Int J Mol Sci. 2025 Mar 19;26(6):2778. doi: 10.3390/ijms26062778.
5
Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments.
Front Med (Lausanne). 2024 Dec 19;11:1480191. doi: 10.3389/fmed.2024.1480191. eCollection 2024.
6
γδ T cells as critical anti-tumor immune effectors.
Nat Cancer. 2024 Aug;5(8):1145-1157. doi: 10.1038/s43018-024-00798-x. Epub 2024 Jul 26.
9
CTLs heterogeneity and plasticity: implications for cancer immunotherapy.
Mol Cancer. 2024 Mar 21;23(1):58. doi: 10.1186/s12943-024-01972-6.
10
The capability of heterogeneous γδ T cells in cancer treatment.
Front Immunol. 2023 Nov 24;14:1285801. doi: 10.3389/fimmu.2023.1285801. eCollection 2023.

本文引用的文献

1
Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
J Immunol. 2013 Mar 1;190(5):2403-14. doi: 10.4049/jimmunol.1202369. Epub 2013 Jan 25.
4
5
Negative regulation of NKG2D expression by IL-4 in memory CD8 T cells.
J Immunol. 2012 Oct 1;189(7):3480-9. doi: 10.4049/jimmunol.1102954. Epub 2012 Aug 31.
7
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
Cytotherapy. 2012 Oct;14(9):1110-8. doi: 10.3109/14653249.2012.700766. Epub 2012 Jul 17.
9
Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
J Immunol. 2011 Nov 15;187(10):4979-86. doi: 10.4049/jimmunol.1101389. Epub 2011 Oct 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验